2024 AF Symposium Spotlight Session: Intranasal Etripamil in A-Fib Rapid Ventricular Rate

Dr. Jonathan Piccini
Dr. Jonathan Piccini from Duke University Medical Center described a novel nasal medication which could be of major benefit to A-Fib patients suffering from rapid heart rate Rapid Ventricular Rate (RVR).
It works in only 7 minutes. It slows the heart rate and is administered by the patient themselves outside of a health care facility (such as at home).
…to continuing reading my report=>Go to Spotlight Session: Intranasal Etripami.
To read other presentations in this series, go to My Summary Reports Written for Atrial Fibrillation Patients.






